Michael Sassano, a former Wall Street banker turned real estate developer, is known in the US for building 16 large-scale cultivation facilities in Nevada. He left for Europe in 2019 to get a head start in the European cannabis market and launched Somai, a cannabinoid pharmaceutical company based in Lisbon, Portugal. Currently operating in 12 countries, Michael plans to be in 18 by year-end.
We discuss his global strategy and the obstacles he faces as a multi-country operator.
https://www.linkedin.com/company/somaipharma
https://www.linkedin.com/in/michaelsassano3/